Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

Also called NCT07032948

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07032948
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07032948. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-31 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function
Condition
Rapid Arrhythmia
Condition
Atrial Fibrillation (AF)
Condition
Paroxysmal Supraventricular Tachycardia (PSVT)
Intervention (Device)
FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter、EasyStars™ High Density Mapping Catheter、Columbus™ 3D EP Navigation System
Lead sponsor
Shanghai MicroPort EP MedTech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07032948
Content hash
c7342ecdeb52070efd03f9d1ce57799e253273e4b8db3126dd0bebf255e7c8b7